These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 28122064

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
    Karabsheh S, Verma DR, Jain M, Stoddard G, Brunisholz K, Stehlik J, Kfoury A, Gilbert E, Bader F.
    Am J Cardiol; 2011 Dec 15; 108(12):1836-9. PubMed ID: 22133132
    [Abstract] [Full Text] [Related]

  • 24. Association of renin-angiotensin system inhibitors with long-term outcomes in patients with systolic heart failure and moderate-to-severe kidney function impairment.
    Higuchi S, Kohsaka S, Shiraishi Y, Katsuki T, Nagatomo Y, Mizuno A, Sujino Y, Kohno T, Goda A, Yoshikawa T, West Tokyo Heart Failure (WET-HF) Registry Investigators.
    Eur J Intern Med; 2019 Apr 15; 62():58-66. PubMed ID: 30737061
    [Abstract] [Full Text] [Related]

  • 25. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
    Chou YH, Chu TS, Lin SL.
    Nephrology (Carlton); 2018 Oct 15; 23 Suppl 4():121-125. PubMed ID: 30298669
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Renin-angiotensin system blockade in heart failure patients on long-term haemodialysis in Taiwan.
    Tang CH, Chen TH, Wang CC, Hong CY, Huang KC, Sue YM.
    Eur J Heart Fail; 2013 Oct 15; 15(10):1194-202. PubMed ID: 23671265
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
    Lund LH, Benson L, Dahlström U, Edner M.
    JAMA; 2012 Nov 28; 308(20):2108-17. PubMed ID: 23188027
    [Abstract] [Full Text] [Related]

  • 33. Effects of cilostazol and renin-angiotensin system (RAS) blockers on the renal disease progression of Korean patients: a retrospective cohort study.
    Noh Y, Lee J, Shin S, Park I, Bae SK, Oh E, Lee S.
    Int J Clin Pharm; 2018 Feb 28; 40(1):160-168. PubMed ID: 29282632
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.
    Miyajima A, Yazawa S, Kosaka T, Tanaka N, Shirotake S, Mizuno R, Kikuchi E, Oya M.
    Ann Surg Oncol; 2015 Oct 28; 22(11):3751-9. PubMed ID: 25691280
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.
    Shenoy SV, Nagaraju SP, Bhojaraja MV, Prabhu RA, Rangaswamy D, Rao IR.
    Nephrology (Carlton); 2021 Nov 28; 26(11):858-871. PubMed ID: 34176194
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.